Cough medicine repurposed to fight dementia with lewy bodies
Disease control
Recruiting now
This Phase 2 trial tests whether ambroxol, a common cough medicine ingredient, can slow cognitive decline and improve symptoms in people with early dementia with Lewy bodies. 180 participants will receive either ambroxol or a placebo for 18 months. The study measures changes in t…
Phase: PHASE2 • Sponsor: Helse Fonna • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC